Apolipoprotein-E degradation in human very low density lipoproteins by plasma protease(s): chemical and biological consequences.
D000595:Amino Acid Sequence; D001053:Apolipoproteins / Q000097:blood*; D001057:Apolipoproteins E; D002478:Cells, Cultured; D010450:Endopeptidases / Q000097:blood*; D005347:Fibroblasts / Q000378:metabolism; D006801:Humans; D006903:Hydroxymethylglutaryl CoA Reductases / Q000378:metabolism; D007700:Kinetics; D008074:Lipoproteins / Q000502:physiology; D008077:Lipoproteins, LDL / Q000378:metabolism; D008079:Lipoproteins, VLDL / Q000097:blood*; D008970:Molecular Weight; D010446:Peptide Fragments / Q000032:analysis; D011956:Receptors, Cell Surface / Q000378:metabolism; D011973:Receptors, LDL; D012697:Serine Endopeptidases; D012867:Skin / Q000378:metabolism; D013917:Thrombin / Q000378:metabolism
D001053:Apolipoproteins; D001057:Apolipoproteins E; D008074:Lipoproteins; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D010446:Peptide Fragments; D011956:Receptors, Cell Surface; D011973:Receptors, LDL; D006903:Hydroxymethylglutaryl CoA Reductases; D010450:Endopeptidases; D012697:Serine Endopeptidases; D013917:Thrombin